🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Research Site 1
Start Date
2018-03-12
Trial ID
NCT03362242
Treatments Being Tested
The purpose of AROAAT2001 (SEQUOIA) is to evaluate the safety, efficacy and...
Status
Completed
Location
Research Site 5
Start Date
2019-08-07
Trial ID
NCT03945292
Treatments Being Tested
The purpose of this study is to evaluate the the safety and efficacy of the...
Status
Completed
Location
Research Center 1
Start Date
2019-10-31
Trial ID
NCT03946449
Treatments Being Tested
The main aim of this study is to learn if fazirsiran is safe during long-te...
Status
Active Not Recruiting
Location
UCSD Altman Clinical and Translational Research Institute
Start Date
2023-08-08
Trial ID
NCT05899673
Treatments Being Tested
The liver produces a protein called alpha-1 antitrypsin (AAT). AAT is norma...
Status
Recruiting
Location
St Joseph's Hospital and Medical Center
Start Date
2024-03-01
Trial ID
NCT06165341
Treatments Being Tested
The main aim of this study is to learn if fazirsiran reduces liver scarring...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-03-06
Trial ID
NCT05677971
Treatments Being Tested